Literature DB >> 1910274

Neuritic pathology and dementia in Alzheimer's disease.

A C McKee1, K S Kosik, N W Kowall.   

Abstract

Previous studies of Alzheimer's disease (AD) have correlated the severity of dementia with either the number of senile plaques or neurofibrillary tangles. We used antibodies raised against amyloid beta/A4 protein of senile plaque cores and tau protein as well as thioflavine S and the Campbell-Switzer modification of the Hicks silver method to examine the hippocampal formation and five neocortical regions from 22 nondemented elderly control subjects and 34 demented patients with cerebral senile plaques and neurofibrillary tangles, without complicating disease processes. Ten control subjects (46%) had no beta/A4 protein deposition. Twelve control subjects (54%) had widespread beta/A4 protein deposition but no neocortical neuritic pathology. Of the 34 patients with AD-type changes, 27 (79%) had widespread senile plaques and neurofibrillary tangles, while 7 (21%) had neocortical senile plaques with few neurofibrillary tangles. All demented patients had widespread beta/A4 protein deposition and neocortical tau-immunoreactive, Hicks silver-positive dystrophic neurites. The neurites were found both free in the neuropil as well as surrounding senile plaques. Quantitative analysis showed that dystrophic neurites were significantly increased in patients with AD compared with control subjects and the number of dystrophic neurites and neurofibrillary tangles correlated with the clinical severity of dementia. Widespread cerebral beta/A4 protein deposition may be necessary but by itself is insufficient for the development of dementia in AD.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1910274     DOI: 10.1002/ana.410300206

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  75 in total

1.  Cholinergic nicotinic systems in Alzheimer's disease: prospects for pharmacological intervention.

Authors:  Robyn Vesey; Jennifer M Birrell; Clare Bolton; Ruth S Chipperfield; Andrew D Blackwell; Tom R Dening; Barbara J Sahakian
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

2.  A physics-informed geometric learning model for pathological tau spread in Alzheimer's disease.

Authors:  Tzu-An Song; Samadrita Roy Chowdhury; Fan Yang; Heidi I L Jacobs; Jorge Sepulcre; Van J Wedeen; Keith A Johnson; Joyita Dutta
Journal:  Med Image Comput Comput Assist Interv       Date:  2020-09-29

3.  Rosiglitazone rescues memory impairment in Alzheimer's transgenic mice: mechanisms involving a reduced amyloid and tau pathology.

Authors:  Luis Escribano; Ana-María Simón; Esther Gimeno; Mar Cuadrado-Tejedor; Rakel López de Maturana; Ana García-Osta; Ana Ricobaraza; Alberto Pérez-Mediavilla; Joaquín Del Río; Diana Frechilla
Journal:  Neuropsychopharmacology       Date:  2010-03-24       Impact factor: 7.853

4.  Characterization of Japanese-American men with a single neocortical AD lesion type.

Authors:  Helen Petrovitch; G Webster Ross; Qimei He; Jane Uyehara-Lock; William Markesbery; Daron Davis; James Nelson; Kamal Masaki; Lenore Launer; Lon R White
Journal:  Neurobiol Aging       Date:  2007-05-17       Impact factor: 4.673

5.  Neurofibrillary tangle predominant form of senile dementia of Alzheimer type: a rare subtype in very old subjects.

Authors:  C Bancher; K A Jellinger
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

6.  Further observations on Tau-positive glia in the brains with progressive supranuclear palsy.

Authors:  T Yamada; D B Calne; H Akiyama; E G McGeer; P L McGeer
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

7.  Ethanol inhibits insulin receptor substrate-1 tyrosine phosphorylation and insulin-stimulated neuronal thread protein gene expression.

Authors:  Y Y Xu; K Bhavani; J R Wands; S M de la Monte
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

8.  Alzheimer's changes in non-demented and demented patients: a statistical approach to their relationships.

Authors:  D Langui; A Probst; J Ulrich
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

9.  Aberrant activation of focal adhesion proteins mediates fibrillar amyloid beta-induced neuronal dystrophy.

Authors:  Elizabeth A Grace; Jorge Busciglio
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

10.  Morphological characterization of Thioflavin-S-positive amyloid plaques in transgenic Alzheimer mice and effect of passive Abeta immunotherapy on their clearance.

Authors:  Thierry Bussière; Frédérique Bard; Robin Barbour; Henry Grajeda; Terry Guido; Karen Khan; Dale Schenk; Dora Games; Peter Seubert; Manuel Buttini
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.